In our dataset, GPX2 was significantly overexpressed in breast cancer samples with BRCA1 promoter inactivation and identified as a hub gene, suggesting a potential role in tumor progression under BRCA1-deficient conditions. This evidence concerns the gene GPX2 and neoplasm.